{"filings":[{"id":3625556,"accession_number":"0001193125-26-429129","cik":2153598,"company_name":"Frazier Life Sciences Acquisition Corp. II","ticker":"FLSC","form_type":"8-K","filed_at":"2026-10-22T21:24:25+00:00","items":["8.01","9.01"],"status":"ready","headline":"Frazier Life Sciences Acquisition Corp. II closes $75M IPO and $3M sponsor private placement","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["IPO of 7,500,000 Class A ordinary shares at $10.00 per share generated $75,000,000 gross proceeds; offering costs were $4,111,319.","Sponsor Frazier Life Sciences Holdings II, LLC bought 300,000 Class A shares at $10.00 in a $3,000,000 private placement closed simultaneously with the IPO.","$75,000,000 was deposited in a U.S. trust account with Continental Stock Transfer & Trust Company as trustee; cash outside the trust was $1,762,481.","Balance sheet shows $3,000,000 deferred underwriting fee payable plus a $750,000 upfront underwriting discount; accumulated deficit of $1,226,690 as of October 15, 2026.","Company has not selected a business combination target or held substantive talks; it has 24 months from the IPO close to consummate a deal."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":null,"market_cap_as_of_date":null,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":3485317,"accession_number":"0001193125-26-422919","cik":2153598,"company_name":"Frazier Life Sciences Acquisition Corp. II","ticker":"FLSC","form_type":"8-K","filed_at":"2026-10-15T20:23:55+00:00","items":["1.01","3.02","5.03","8.01","9.01"],"status":"ready","headline":"Frazier Life Sciences Acquisition Corp. II closes $75M IPO at $10.00; FLSC lists on Nasdaq","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["IPO of 7,500,000 Class A ordinary shares at $10.00 raised $75,000,000 gross; shares began trading on Nasdaq under \"FLSC\" Oct 14, 2026 and the offering closed Oct 15.","Sponsor Frazier Life Sciences Holdings II, LLC bought 300,000 private placement shares at $10.00 ($3,000,000); not transferable until 30 days after an initial business combination.","Forward purchase agreement: Frazier Life Sciences Public Fund, L.P. committed to buy at least 2,500,000 Class A shares at $10.00 ($25,000,000), closing with the business combination.","$75,000,000 placed in trust at Continental Stock Transfer & Trust; up to $100,000 of interest may pay liquidation costs; combination deadline is 24 months from IPO close.","Led by CEO Albert Cha, Chairman Ben Palleiko and CBO Kevin Li; intends to target biotechnology; Jefferies was sole book-running manager."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":null,"market_cap_as_of_date":null,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}